Searchable abstracts of presentations at key conferences in endocrinology

ea0013p78 | Clinical practice/governance and case reports | SFEBES2007

Apparent hypopituitarism secondary to Cushing’s syndrome due to adrenal carcinoma

Revesz Sarah , Knox Andrew , Vaidya Bijay

A 75-year-old lady presented with hypertension, weight gain, ankle oedema and proximal myopathy. She had clinical features of Cushing’s syndrome. Blood pressure was 180/99 mmHg. Her visual fields were normal. Investigations confirmed Cushing’s syndrome with high 24-hour free urinary cortisol levels (2264 nmol/l and 3295 nmol/l; normal range 40–305) and a high serum cortisol level following overnight dexamethasone suppression test (serum cortisol 1,550 nmol/l). F...

ea0021ye1.2 | Alternative careers for basic and clinical scientists | SFEBES2009

Clinical biochemistry: one foot in the lab

Knox Susan

Clinical biochemistry is a branch of laboratory medicine in which chemical and biochemical methods are used to detect changes in the composition of body fluids (e.g. blood) as a result of disease. The results of biochemical tests may be of use in screening for disease, diagnosis, monitoring treatment and assessing prognosis. This presentation will focus on the role of the clinical biochemist, who works as part of a team including chemical pathologists and biomedical scientists...

ea0028p193 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Annexin A1, an anti-inflammatory regulator, is expressed in human adipocytes

Kosicka-Knox Anna , Cunliffe Adam , Mackenzie Richard , Zariwala Mohammed , Renshaw Derek

Annexin A1 (AnxA1), an endogenous glucocorticoid regulated protein, is a pivotal homeostatic regulator of the magnitude of the inflammatory response. We have previously demonstrated that plasma AnxA1 protein is significantly inversely correlated with waist to hip ratio (P=0.017). Given that low-level systemic inflammation is seen in metabolic syndrome-associated chronic pathologies, here, we investigate if AnxA1 is also involved in the regulation of adipose tissue infla...

ea0019s8biog | Society for Endocrinology Medal Lecture | SFEBES2009

Society for Endocrinololgy Medal Lecture

Hattersley Andrew

Andrew Hattersley, Peninsula Medical School, Plymouth, UK AbstractAndrew Hattersley qualified from Oxford in 1984. He trained in Diabetes at the Hammersmith Hospital, Oxford and Birmingham before taking up his present post as a consultant Diabetologist in Exeter in 1995.His principal area of research is the molecular genetics of diabetes with a particular emphasis on monogenic diabetes. He has ta...

ea0021p61 | Clinical practice/governance and case reports | SFEBES2009

Hyperandrogenism with an abdominal mass but an ovarian source

Knox Susan , Perry Colin

A 55-year-old female presented to her General Practitioner with hirsutism, male pattern baldness, weight gain and a deepening of voice. Her past medical history included well controlled type 2 diabetes on gliclazide, and hysterectomy for menorrhagia. She had an elevated serum testosterone after solvent extraction (18 nmol/l) and free androgen index (17.6). The patient was referred for further investigation.17-Hydroxyprogesterone and dehydroepiandrosteron...

ea0024oc2.2 | Oral Communications 2 (Brief Communications) | BSPED2010

An unbalanced maternal diet in pregnancy is associated with epigenetic effects in the offspring

Drake A , Knox R , Seckl J , Reynolds R

Epigenetic dysregulation may be one mechanism underpinning the link between early life conditions and later cardiometabolic risk. In animal models, environmental manipulations including modified maternal diet change DNA methylation and offspring phenotype. Manipulations altering the epigenetic state reverse the phenotype suggesting causality. We have previously reported higher blood pressure (BP) and cortisol in an adult cohort whose mothers were advised to eat a high-protein,...

ea0029p1172 | Obesity | ICEECE2012

Ac 2-26, an annexin A1-derived peptide, reduces inflammation in human SGBS adipocytes after hypoxia treatment

Kosicka-Knox A. , Cunliffe A. , Mackenzie R. , Zariwala M. , Renshaw D.

Previous studies demonstrated that the N-terminal peptide of annexin A1 (AnxA1) (peptide Ac2-26) can mimic the anti-inflammatory actions of the full-length protein in various systems. In the current study, we report the effectiveness of the peptide Ac2-26 as an anti-inflammatory agent in a model of human SGBS adipocytes. We have previously demonstrated that plasma AnxA1 protein is significantly inversely correlated with BMI, body fat level and waist to hip ratio. We have also ...

ea0019p327 | Steroids | SFEBES2009

Measuring cortisone production in man using a new stable isotope tracer

Hughes K A , Reynolds R M , Andrew R , Walker B R

Background: 11β-hydroxysteroid dehydrogenases (11β-HSD1&2) interconvert cortisol (F) and cortisone (E). Although 11β-HSD1 reductase activity has been measured in vivo, E production (dehydrogenase activity) has not been quantified using a Gold Standard technique, steady state tracer infusion.Aim: To develop a method to measure E production in vivo using the stable isotope tracer d2-cortisone (d2E).Me...

ea0025p133 | Diabetes, metabolism and cardiovascular | SFEBES2011

Plasma Annexin A1 (AnxA1) is inversely correlated with waist to hip ratio in healthy males

Kosicka-Knox Anna , Cunliffe Adam , Mackenzie Richard , Flower Rod , Renshaw Derek

The escalating public health problem represented by obesity has spurred multidisciplinary research into adipose tissue and importantly, the molecular biology of the adipocyte. Recent studies suggest that obesity related metabolic disorders are characterised by chronic mild inflammation as a result of adipocytokine production from fat tissue leading to dysregulation in the pro/anti-inflammatory systemic balance. Adipokines and pro-inflammatory markers are implicated in insulin ...

ea0033p7 | (1) | BSPED2013

Audit on the characteristics and management of patients in a large tertiary hospital paediatric adrenal clinic

Knox Ailie , Ehtisham Sarah , Clayton Peter , Jones Julie , O'Shea Elaine , Patel Leena , Skae Mars , Banerjee Indie , Padidela Raja

Adrenal insufficiency (Adr-I) and congenital adrenal hyperplasia (CAH) are important conditions requiring specialist attention and management. Recent CAH genotype–phenotype studies have linked mutations with enzyme functioning and disease severity. Accurate diagnosis for the cause of adrenal insufficiency and the genetic cause of CAH is vital as it impacts management and prognosis.Methods: We audited patients with Adr-I and CAH seen in outpatients f...